Ποια είναι η τιμή για CHO Pharma, Inc. (6586)

Η τιμή για CHO Pharma, Inc. (6586) είναι $3.47

Ποια είναι η κεφαλαιοποίηση αγοράς για CHO Pharma, Inc. (6586)

Η κεφαλαιοποίηση αγοράς για CHO Pharma, Inc. (6586) είναι $741.78M

CHO Pharma, Inc. (6586) Τιμή και Κεφαλαιοποίηση Αγοράς

CHO Pharma, Inc., a biotechnology firm headquartered in Taipei City, Taiwan, specializes in the research and development of innovative therapeutic solutions. Central to its operations is an advanced glycoengineering platform. This proprietary technology facilitates the creation of several key therapeutic modalities, including SAR-based glycoengineered "biobetters," site-specific antibody-drug conjugates (ADCs), and novel antibodies and vaccines designed to target unique carbohydrate antigens. The company also offers CHOptimax, an innovative in vitro enzymatic single-step process. This technology allows for the precise transformation of unconjugated antibodies into either glycoengineered biobetters or ADCs. CHO Pharma boasts a robust and diverse pipeline of drug candidates spanning various therapeutic areas, all leveraging its glycoengineering expertise. Currently, several programs are in clinical development: CHO-H01 is undergoing Phase I/IIa trials for refractory non-Hodgkin lymphoma, while CHO-A04, a humanized monoclonal antibody, has entered Phase I trials targeting a range of tumor and cancer stem cells. Additionally, CHO-V08 is being developed as a vaccine against Klebsiella pneumoniae. In the preclinical stage, CHO Pharma is advancing CHO-H02, an agent designed to address various solid tumors including breast, bladder, pancreatic, ovarian, and gastric cancers. Another preclinical asset, CHO-H03, is an antibody drug being investigated for inflammatory conditions associated with autoimmune diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease. Established in 2012, CHO Pharma continues to innovate from its base in Taipei City, Taiwan.

Η τιμή για 6586	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$24,596.31 $741.78M	NVDA	$5.264T	+709,526.02%
$21,967.50 $741.78M	AAPL	$4.701T	+633,682.59%
$19,518.56 $741.78M	GOOG	$4.177T	+563,028.51%
$17,837.45 $741.78M	MSFT	$3.817T	+514,526.75%
$13,393.44 $741.78M	AMZN	$2.866T	+386,313.06%

Η τιμή για 6586

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$24,596.31 $741.78M